CVS investors have the opportunity to join the CVS Health Corporation fraud investigation with Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims of violations of the securities laws on behalf of investors in CVS Health Corporation (“CVS” or “the Company”) (NYSE: CVS).

The investigation focuses on whether the company made false and/or misleading statements and/or failed to disclose relevant information to investors. CVS failed to accurately predict trends in medical costs and health care utilization rates. The company was forced to incur significant costs due to its ineffective forecasting. The company overstated the profitability of its Health Care Benefits division. Despite its assurances, the company’s profits from other businesses were insufficient to cover the rising costs of the Health Care Benefits division. Based on these facts, the company’s public statements throughout the Class Period were false and materially misleading. When the market learned the truth about CVS, investors suffered harm.